The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Generon (Shanghai) Corporation
Huangpu District, China
D
51-100 Employees
2004
Key takeaway
Evive Biotech is a global biopharmaceutical company focused on developing innovative biological therapies, particularly in oncology, inflammatory, and metabolic diseases. With a strong pipeline of drug candidates and a commitment to addressing unmet medical needs, the company leverages advanced research and manufacturing capabilities to bring novel treatments to market.
Reference
Core business
Evive Biotech: Develop Novel Therapies for Patients Worldwide
Bioworkshops
Suzhou City, China
D
51-100 Employees
2019
Key takeaway
Bioworkshops is a specialized biologics contract development and manufacturing organization (CDMO) with extensive experience in providing CMC services for late-stage clinical products. Their focus on regulatory affairs and commitment to international GMP compliance supports the rapid approval and market entry of biologic products.
Reference
Core business
Bioworkshops-康日百奥生物科技
Huabei Pharmaceutical Hebei Huawei Health Industry Co., Ltd.
Shijiazhuang, China
D
51-100 Employees
1998
Key takeaway
The company provides a platform that connects users with over 8,000 high-quality suppliers and 3.6 million pharmaceutical products, offering insights into the global pharmaceutical industry.
Reference
Product
Services in Pharmaceutical Industry
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
WuXi Biologics
Xuancheng, China
D
5001-10000 Employees
2014
Key takeaway
WuXi XDC, a subsidiary of WuXi Biologics, specializes in bioconjugation technologies, offering comprehensive development and manufacturing services for antibody-drug conjugates (ADCs) and other bioconjugates. Their expertise includes handling potent payloads and ensuring compliance with global regulatory standards, making them a key player in the biopharmaceutical sector.
Reference
Core business
WuXi Biologics
Biotheus
Zhuhai, China
D
51-100 Employees
2018
Key takeaway
Biotheus is dedicated to the discovery and development of novel biopharmaceuticals, particularly targeting cancer and inflammatory diseases. With a pipeline of over 20 products, several are currently in clinical trials in China.
Reference
Core business
Biotheus
Biocytogen
Daxing District, China
D
1001-5000 Employees
2008
Key takeaway
Biocytogen specializes in next-generation antibody drug development, offering integrated solutions that streamline the discovery and development of fully human monoclonal antibodies, bispecific antibodies, and nanobodies. Their innovative platforms, including the RenNano, enhance biopharmaceutical research and preclinical testing.
Reference
Core business
Antibody Discovery, Models & Preclinical Testing | Biocytogen
Biocytogen partners with researchers to provide high-quality gene-editing services, animal models, preclinical efficacy testing and antibody discovery services.
BRIM Biotechnology
Nanping City, China
D
- Employees
2013
Key takeaway
The company, BRIM Biotechnology, focuses on developing innovative biopharmaceuticals that aim to cure diseases and improve patient lives, emphasizing affordability and accessibility. Their expertise in translational science has led to the advancement of several drug discoveries, including a first-in-class treatment for Dry Eye Disease.
Reference
Core business
BRIM Biotechnology | About Us
We seek out the drug discoveries that have the highest potential to defeat diseases, creating value for patients, partners, and investors.
Biointron Biological Inc.
Taizhou, China
D
251-500 Employees
2012
Key takeaway
Biointron is a prominent provider of high-throughput recombinant antibody and protein expression services, having delivered tens of thousands of recombinant antibodies to over 1,500 biotech and pharma companies globally. Their commitment to advancing biotechnology through innovative research and development aligns with the broader goals of the biopharmaceutical industry to improve human health.
Reference
Core business
About Biointron-Biointron-Antibody Discovery | Antibody Production | Stable cell line | Protein Expression | CRO
Shanghai IVEN Pharmatech Engineering Co. Ltd
Huangpu District, China
D
251-500 Employees
2003
Key takeaway
The company specializes in providing integrated engineering solutions for pharmaceutical and medical factories, ensuring compliance with international GMP standards. They are currently constructing a Soft Bag IV-Solution Pharmaceutical Factory in Nigeria, capable of producing 20 million soft bags annually, highlighting their expertise in the biopharmaceutical sector.
Reference
Core business
About the Company
Sundia MediTech
Huangpu District, China
D
501-1000 Employees
2004
Key takeaway
BioDuro-Sundia is a prominent contract research, development, and manufacturing organization (CRDMO) with over 28 years of experience, specializing in both small and large molecule discovery, development, scale-up, and manufacturing. They leverage unique technology platforms to support biotech and pharmaceutical partners, offering fully integrated services that accelerate development timelines.
Reference
Core business
Home-BioDuro-Sundia
Technologies which have been searched by others and may be interesting for you:
When exploring the Biopharmaceutical industry in China, there are several key considerations to keep in mind. First, understanding the regulatory environment is crucial, as China's National Medical Products Administration (NMPA) oversees drug approval processes, which can be complex and time-consuming. The rapid growth of the industry presents significant opportunities, particularly in areas such as biologics, cell therapy, and innovative drug development. However, companies face challenges including intellectual property protection, which remains a concern despite recent reforms. The competitive landscape is intense, with both domestic and international players vying for market share, leading to a dynamic environment where innovation is essential. Additionally, the global relevance of China's biopharmaceutical sector is increasing, as it is becoming a major hub for research and development, driven by investments and collaborations. Environmental considerations are also becoming more prominent, as companies are urged to adopt sustainable practices and address the ecological impact of their operations. Finally, keeping an eye on evolving market trends and consumer demands is vital, as the Chinese populace becomes more health-conscious and open to novel therapies. This multifaceted landscape necessitates thorough research and strategic planning for anyone looking to engage with the biopharmaceutical sector in China.
Some interesting numbers and facts about your company results for Biopharmaceutical
| Country with most fitting companies | China |
| Amount of fitting manufacturers | 187 |
| Amount of suitable service providers | 102 |
| Average amount of employees | 251-500 |
| Oldest suiting company | 1998 |
| Youngest suiting company | 2019 |
Some interesting questions that has been asked about the results you have just received for Biopharmaceutical
What are related technologies to Biopharmaceutical?
Based on our calculations related technologies to Biopharmaceutical are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Biopharmaceutical?
The most represented industries which are working in Biopharmaceutical are Biotechnology, Pharmaceuticals, Other, Medical, Chemicals
How does ensun find these Biopharmaceutical Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
